NCT00323817View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

October 31, 2009

Conditions
Functional Dyspepsia
Interventions
DRUG

Z-338

Trial Locations (1)

Unknown

Leuven University, Leuven

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY

NCT00323817 - To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia | Biotech Hunter | Biotech Hunter